enVVeno Medical (NVNO) Other Accumulated Expenses (2020 - 2026)

enVVeno Medical's Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $81000.0 for Q1 2026.

• On a quarterly basis, Other Accumulated Expenses changed N/A year-over-year to $81000.0 in Q1 2026; TTM through Mar 2026 was $81000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $134000.0, up 10.74% from the prior year.
• Other Accumulated Expenses retreated to $81000.0 in Q1 2026 per NVNO's latest filing, from $134000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $134000.0 in Q4 2025 and bottomed at $59000.0 in Q2 2022.
• The 4-year median for Other Accumulated Expenses is $81000.0 (2026), against an average of $91000.0.
• Biggest YoY gain for Other Accumulated Expenses was 10.74% in 2025; the steepest drop was 10.74% in 2025.
• Year by year, Other Accumulated Expenses stood at $59000.0 in 2022, then surged by 105.08% to $121000.0 in 2024, then grew by 10.74% to $134000.0 in 2025, then plunged by 39.55% to $81000.0 in 2026.
• Per Business Quant, the three latest NVNO Other Accumulated Expenses figures stand at $81000.0 (Q1 2026), $134000.0 (Q4 2025), and $121000.0 (Q4 2024).